Wednesday 8/19 Insider Buying Report: BSX, CERS Wednesday, August 19, 10:32 AM ET
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Boston Scientific (BSX), a filing with the SEC revealed that on Monday, John E. Abele bought 100,000 shares of BSX, at a cost of $17.50 each, for a total investment of $1.75M. So far Abele is down about 0.8% on the buy, with shares trading as low as $17.36 at last check today. Boston Scientific is trading down about 0.7% on the day Wednesday. This buy marks the first one filed by Abele in the past year.
And at Cerus (CERS), there was insider buying on Tuesday, by Chief Scientific Officer Laurence M. Corash who purchased 84,600 shares at a cost of $4.77 each, for a total investment of $403,465. Before this latest buy, Corash purchased CERS on 2 other occasions during the past year, for a total cost of $369,595 at an average of $4.93 per share. Cerus is trading down about 1.6% on the day Wednesday. So far Corash is in the green, up about 7.1% on their buy based on today's trading high of $5.11.
For MarketNewsVideo.com, I'm Sayoko Murase.
|